Understanding and Reducing Cardiovascular and Cardiometabolic Risks [CE Podcast]

ASCVD risk reduction for patients with--or at risk for--Type 2 Diabetes

Member Cost: $0Non-member Cost: $0
Credits: 0.6 CE contact hours, 0.0 CE pharmacology hours

Course Overview

Nancy Albert, APN, and Rimsky Denis, MD, discuss current studies in ASCVD risk reduction for patients with–or at risk for–Type 2 Diabetes. They also describe strategies for shared decision-making in clinical practice for managing cardiovascular disease and diabetes.

Earn 0.6 CE contact hours from listening to the podcast episode and completing the course components.

Member Cost: $0Non-member Cost: $0
Credits: 0.6 CE contact hours, 0.0 CE pharmacology hours

Register

Learning Objectives

1. Examine current studies in ASCVD risk reduction for patients with or at risk for Type 2 Diabetes
2. Describe the benefits of team-based care in cardiovascular and diabetes management

CE certificate available upon successful completion of the post-test and program evaluation.

Faculty

  • Nancy Albert, APN
  • Rimsky Denis, MD
Full_Color_Provider

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.